In The Media STAT News
FDA Review Staff was Excluded from Voting on Whether to Approve First Priority Voucher Drug
Interview
Search Results
These Patients Have Nothing Else. Should That Be Enough for FDA Drug Approval?
Despite Streamlined Processes, FDA’s Role in Rare-Disease Drug Development Draws Continued Scrutiny
In The Media KFF Health News
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Interview
Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
In The Media The Guardian
Patients with Ultra-Rare Diseases Worry FDA Approach Will Leave Them Without Treatment
Interview
In The Media STAT News
‘We’re Living In The Twilight Zone’: Researchers Decry Trump Administration Assault On Science
Interview